Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF MAY 22, 2013 FBO #4197
SOURCES SOUGHT

66 -- Small Animal Cesium- 137 Irradiator, Disposal of Gamma Cell 40, and Relocation of GammaCell 1000 Irradiator

Notice Date
5/20/2013
 
Notice Type
Sources Sought
 
NAICS
334517 — Irradiation Apparatus Manufacturing
 
Contracting Office
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 3900 NCTR Road, HFT-320, Bldg 50 | Rm 421, Jefferson, Arkansas, 72079, United States
 
ZIP Code
72079
 
Solicitation Number
FDA-SS-1115565
 
Archive Date
6/18/2013
 
Point of Contact
Christopher R. McGucken, Phone: 3018277161
 
E-Mail Address
christopher.mcgucken@fda.hhs.gov
(christopher.mcgucken@fda.hhs.gov)
 
Small Business Set-Aside
N/A
 
Description
TITLE: Small Animal Cesium- 137 Irradiator, Disposal of Gamma Cell 40, and Relocation of GammaCell 1000 Irradiator OPDIV: FDA, Center for Drug Evaluation and Research This is a SOURCES SOUGHT NOTICE to determine the availability of potential small businesses (e.g., 8(a), service-disabled veteran owned small business, HUBZone small business, small disadvantaged business, veteran-owned small business, and women-owned small business) in accordance with FAR 7.104(d). The potential small business will need to demonstrate the capability to perform all facets of the work described below. The sole intent of this Sources Sought Notice is to obtain capabilities for set-aside and procurement planning purposes. This is not an invitation for bid, request for proposal, or other solicitation, and in no way obligates the Food and Drug Administration (FDA) to award a contract. BACKGROUND Research in DTP studies the effect of radiation on the immune system, and is investigating ways to mitigate the damage done. The dose rate of the present irradiator has dropped below a level at which research is valid. A new unit is required to replace the current irradiator to continue the generation of humanized mice. In addition, another irradiator is to be moved from NIH headquarters to a new location at the FDA’s new White Oak Campus, currently under construction. CONTRACTOR REQUIREMENTS Contractors must respond to all of the following points by describing your experience and capabilities in the areas listed below: 1.) Proper licensing required for the transportation and disposal of a GammaCell 1000 Irradiator and GammaCell 40. 2.) Ability to produce and deliver one (1) small animal cesium-137 irradiator with the following salient characteristics: a.) Dual cesium-137 source. b.) Base Rate of at least 100 cGy/minute. c.) Dose uniformity of +/-10% d.) Safety Interlock System for source e.) Air Compressor f.) Chamber dimensions (round) of at least 4 in. height x 12 in. diameter. g.) Battery Backup h.)Compressor i.) Air-pump j.) Attenuators Capability statements must demonstrate the minimum requirements outlined above. Please address each in the order listed above. Please provide the follow Business information: DUNS Number Company Name Company Address. Company Point of Contact, phone number and email address Type of company under NAICS, as validated via the System for Award Management (SAM). Additional information on NAICS codes can be found at www.sba.gov. Any potential government contract must be registered on the SAM located at http://www.sam.gov/index.asp. Corporate structure (corporation, LLC, sole proprietorship, partnership, limited liability partnership, professional corporation, etc.); Current GSA Schedules appropriate to this Sources Sought Current Government Wide Agency Contracts (GWACs) Point of Contact, phone number and email address of individuals who can verify the demonstrated capabilities identified in the responses. Interested parties having the capabilities necessary to perform the stated requirements may submit capability statements via email or regular mail to the point of contact listed below. Responses shall be limited to 10 pages. Responses must be received not later than 12:00 PM Noon EST, June 3rd, 2013. Capability statements will not be returned and will not be accepted after the due date. Documentation should be emailed to: Christopher.McGucken@fda.hhs.gov
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/FDA-SS-1115565/listing.html)
 
Place of Performance
Address: Food & Drug Administration, Vivarium Bldg. 10 Rm. 0132, Silver Sping, Maryland, 20993, United States
Zip Code: 20993
 
Record
SN03066573-W 20130522/130520234520-2a15d6f6a83835b792594b37026b3b0a (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.